Published in Stem Cells Dev on October 01, 2008
Conjoint propagation and differentiation of human embryonic stem cells to cardiomyocytes in a defined microcarrier spinner culture. Stem Cell Res Ther (2014) 0.80
Clinical translation of stem cells: insight for cartilage therapies. Crit Rev Biotechnol (2013) 0.80
Multiple mesodermal lineage differentiation of Apodemus sylvaticus embryonic stem cells in vitro. BMC Cell Biol (2010) 0.77
In vivo repair of full-thickness cartilage defect with human iPSC-derived mesenchymal progenitor cells in a rabbit model. Exp Ther Med (2017) 0.75
Third-generation biomedical materials. Science (2002) 3.89
Derivation of distal airway epithelium from human embryonic stem cells. Tissue Eng (2006) 1.60
In vitro differentiation and in vivo mineralization of osteogenic cells derived from human embryonic stem cells. Tissue Eng (2004) 1.59
Derivation of distal lung epithelial progenitors from murine embryonic stem cells using a novel three-step differentiation protocol. Stem Cells (2006) 1.52
Derivation of type II alveolar epithelial cells from murine embryonic stem cells. Tissue Eng (2002) 1.42
ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med (2002) 1.39
Chondrogenic differentiation of human embryonic stem cells: the effect of the micro-environment. Tissue Eng (2006) 1.36
The use of murine embryonic stem cells, alginate encapsulation, and rotary microgravity bioreactor in bone tissue engineering. Biomaterials (2008) 1.30
Differentiating embryonic stem cells: GAPDH, but neither HPRT nor beta-tubulin is suitable as an internal standard for measuring RNA levels. Tissue Eng (2002) 1.20
Control of human articular chondrocyte differentiation by reduced oxygen tension. J Cell Physiol (2004) 1.19
Stem cell bioprocessing: fundamentals and principles. J R Soc Interface (2009) 1.17
Chondrogenic differentiation of murine embryonic stem cells: effects of culture conditions and dexamethasone. J Cell Biochem (2004) 1.15
Bioactive glasses for in situ tissue regeneration. J Biomater Sci Polym Ed (2004) 1.14
Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing. Expert Opin Investig Drugs (2009) 1.13
The benefit of human embryonic stem cell encapsulation for prolonged feeder-free maintenance. Biomaterials (2008) 1.12
Differentiation of fetal osteoblasts and formation of mineralized bone nodules by 45S5 Bioglass conditioned medium in the absence of osteogenic supplements. Biomaterials (2009) 1.09
TGF-beta3: A potential biological therapy for enhancing chondrogenesis. Expert Opin Biol Ther (2009) 1.07
Engineering a mimicry of bone marrow tissue ex vivo. J Biosci Bioeng (2005) 1.06
Cell extract-derived differentiation of embryonic stem cells. Stem Cells (2005) 1.05
Bioadhesive hydrogel microenvironments to modulate epithelial morphogenesis. Biomaterials (2008) 1.04
Biological therapy of bone defects: the immunology of bone allo-transplantation. Expert Opin Biol Ther (2010) 1.04
More than meets the eye in bacterial cellulose: biosynthesis, bioprocessing, and applications in advanced fiber composites. Macromol Biosci (2013) 1.01
Binary CaO-SiO(2) gel-glasses for biomedical applications. Biomed Mater Eng (2004) 0.99
Differentiation of osteoblasts from murine embryonic stem cells by overexpression of the transcriptional factor osterix. Tissue Eng (2004) 0.97
Cigarette smoke decreases inducible nitric oxide synthase in lung epithelial cells. Exp Lung Res (2003) 0.97
Extracellular matrix-mediated osteogenic differentiation of murine embryonic stem cells. Biomaterials (2010) 0.96
Extracellular matrix formation and mineralization on a phosphate-free porous bioactive glass scaffold using primary human osteoblast (HOB) cells. Biomaterials (2006) 0.96
Autonomic nerve trauma at radical hysterectomy: the nerve content and subtypes within the superficial and deep uterosacral ligaments. Reprod Sci (2008) 0.94
Pelvic nerve plexus trauma at radical and simple hysterectomy: a quantitative study of nerve types in the uterine supporting ligaments. J Soc Gynecol Investig (2002) 0.93
Surface modification of natural fibers using bacteria: depositing bacterial cellulose onto natural fibers to create hierarchical fiber reinforced nanocomposites. Biomacromolecules (2008) 0.93
Preclinical and clinical data for the use of mesenchymal stem cells in articular cartilage tissue engineering. Expert Opin Biol Ther (2012) 0.93
Integrated 3-dimensional expansion and osteogenic differentiation of murine embryonic stem cells. Tissue Eng (2007) 0.92
Nondestructive technique for the characterization of the pore size distribution of soft porous constructs for tissue engineering. Langmuir (2006) 0.91
Anti-inflammatory role and immunomodulation of mesenchymal stem cells in systemic joint diseases: potential for treatment. Expert Opin Ther Targets (2013) 0.90
Long-term cytokine-free expansion of cord blood mononuclear cells in three-dimensional scaffolds. Biomaterials (2011) 0.90
Development of a novel three-dimensional, automatable and integrated bioprocess for the differentiation of embryonic stem cells into pulmonary alveolar cells in a rotating vessel bioreactor system. Tissue Eng Part C Methods (2012) 0.90
Proliferation rates of HepG2 cells encapsulated in alginate are increased in a microgravity environment compared with static cultures. Artif Organs (2005) 0.89
Characterization of human fetal osteoblasts by microarray analysis following stimulation with 58S bioactive gel-glass ionic dissolution products. J Biomed Mater Res B Appl Biomater (2006) 0.89
The development of a three-dimensional scaffold for ex vivo biomimicry of human acute myeloid leukaemia. Biomaterials (2009) 0.89
Application of global sensitivity analysis to determine goals for design of experiments: an example study on antibody-producing cell cultures. Biotechnol Prog (2005) 0.89
Cloning and tissue distribution of three murine alpha/beta hydrolase fold protein cDNAs. Biochem Biophys Res Commun (2002) 0.88
Intelligent bioprocessing for haemotopoietic cell cultures using monitoring and design of experiments. Biotechnol Adv (2007) 0.88
Time- and concentration-dependent effects of dissolution products of 58S sol-gel bioactive glass on proliferation and differentiation of murine and human osteoblasts. Tissue Eng (2004) 0.87
Enhanced derivation of osteogenic cells from murine embryonic stem cells after treatment with ionic dissolution products of 58S bioactive sol-gel glass. Tissue Eng (2005) 0.87
Upregulated genes in sporadic, idiopathic pulmonary arterial hypertension. Respir Res (2006) 0.87
Historic and current strategies in bone tissue engineering: do we have a hope in Hench? J Mater Sci Mater Med (2006) 0.86
Stem cells combined with bone graft substitutes in skeletal tissue engineering. Expert Opin Biol Ther (2012) 0.85
Dose- and time-dependent effect of bioactive gel-glass ionic-dissolution products on human fetal osteoblast-specific gene expression. J Biomed Mater Res B Appl Biomater (2005) 0.85
The effect of hyperosmotic pressure on antibody production and gene expression in the GS-NS0 cell line. Biotechnol Appl Biochem (2004) 0.84
Modelling the Delta1/Notch1 pathway: in search of the mediator(s) of neural stem cell differentiation. PLoS One (2011) 0.84
Antibiotics reduce the growth rate and differentiation of embryonic stem cell cultures. Tissue Eng (2006) 0.84
Cross-linked bacterial cellulose networks using glyoxalization. ACS Appl Mater Interfaces (2010) 0.84
Use of green fluorescent fusion protein to track activation of the transcription factor osterix during early osteoblast differentiation. Biochem Biophys Res Commun (2005) 0.83
Effect of nitric oxide donor nitroglycerin on bone mineral density in a rat model of estrogen deficiency-induced osteopenia. Bone (2003) 0.83
Stem cells in regenerative medicine: introduction. Br Med Bull (2011) 0.83
Immunocytochemical evidence for inducible nitric oxide synthase and cyclooxygenase-2 expression with nitrotyrosine formation in human hibernating myocardium. Basic Res Cardiol (2002) 0.83
Development and analysis of a mathematical model for antibody-producing GS-NS0 cells under normal and hyperosmotic culture conditions. Biotechnol Prog (2006) 0.82
Linking genes to microbial growth kinetics: an integrated biochemical systems engineering approach. Metab Eng (2011) 0.81
Embryonic stem cells. J Pathol (2002) 0.81
Skeletal tissue engineering using mesenchymal or embryonic stem cells: clinical and experimental data. Expert Opin Biol Ther (2014) 0.81
Growth hormone: does it have a therapeutic role in fracture healing? Expert Opin Investig Drugs (2009) 0.80
Simvastatin induces osteogenic differentiation of murine embryonic stem cells. J Bone Miner Res (2010) 0.80
Computational approach for understanding and improving GS-NS0 antibody production under hyperosmotic conditions. J Biosci Bioeng (2011) 0.79
The basic science of bone induction. Br J Oral Maxillofac Surg (2009) 0.79
Proteomic characterization of the conditioned media produced by the visceral endoderm-like cell lines HepG2 and END2: toward a defined medium for the osteogenic/chondrogenic differentiation of embryonic stem cells. Stem Cells Dev (2010) 0.79
Disease-modifying osteoarthritis drugs: in vitro and in vivo data on the development of DMOADs under investigation. Expert Opin Investig Drugs (2013) 0.79
Enhanced hematopoietic differentiation toward erythrocytes from murine embryonic stem cells with HepG2-conditioned medium. Stem Cells Dev (2012) 0.79
Prostaglandin EP2 and EP4 receptor agonists in bone formation and bone healing: In vivo and in vitro evidence. Expert Opin Investig Drugs (2009) 0.79
Ex vivo mimicry of normal and abnormal human hematopoiesis. J Vis Exp (2012) 0.79
The regulatory logic of m-xylene biodegradation by Pseudomonas putida mt-2 exposed by dynamic modelling of the principal node Ps/Pr of the TOL plasmid. Environ Microbiol (2010) 0.79
Modeling amino acid metabolism in mammalian cells-toward the development of a model library. Biotechnol Prog (2007) 0.79
Early exposure of murine embryonic stem cells to hematopoietic cytokines differentially directs definitive erythropoiesis and cardiomyogenesis in alginate hydrogel three-dimensional cultures. Stem Cells Dev (2014) 0.79
Stability and performance of Xanthobacter autotrophicus GJ10 during 1,2-dichloroethane biodegradation. Appl Environ Microbiol (2006) 0.78
Modeling and analysis of individualized pharmacokinetics and pharmacodynamics for volatile anesthesia. IEEE Trans Biomed Eng (2013) 0.78
iNOS gene upregulation is associated with the early proliferative response of human lung fibroblasts to cytokine stimulation. J Pathol (2002) 0.78
An oil-absorber-bioscrubber system to stabilize biotreatment of pollutants present in waste gas. Fluctuating loads of 1,2-dichloroethane. Environ Sci Technol (2006) 0.78
Improving embryonic stem cell expansion through the combination of perfusion and Bioprocess model design. PLoS One (2013) 0.78
An in silico erythropoiesis model rationalizing synergism between stem cell factor and erythropoietin. Bioprocess Biosyst Eng (2013) 0.77
The incorporation of 70s bioactive glass to the osteogenic differentiation of murine embryonic stem cells in 3D bioreactors. J Tissue Eng Regen Med (2009) 0.77
Perspectives in regenerative medicine and tissue engineering of bone. Br J Oral Maxillofac Surg (2010) 0.76
A Personalized Framework for Dynamic Modeling of Disease Trajectories in Chronic Lymphocytic Leukemia. IEEE Trans Biomed Eng (2016) 0.76
In vitro direct osteogenesis of murine embryonic stem cells without embryoid body formation. Stem Cells Dev (2008) 0.76
Osteoinduction: translating preclinical promise into clinical reality. Br J Oral Maxillofac Surg (2010) 0.76
A novel perfused rotary bioreactor for cardiomyogenesis of embryonic stem cells. Biotechnol Lett (2014) 0.76
Prostaglandin E(2) receptors as potential bone anabolic targets - selective EP4 receptor agonists. Curr Mol Pharmacol (2012) 0.76
Pulmonary epithelium. Methods Enzymol (2006) 0.76
Free energy predictions of ligand binding to an α-helix using steered molecular dynamics and umbrella sampling simulations. J Chem Inf Model (2014) 0.76
The potential adverse effects of aromatase inhibitors on wound healing: in vitro and in vivo evidence. Expert Opin Drug Saf (2009) 0.76
Nitric oxide in the development of obliterative bronchiolitis in a heterotopic pig model. Transplantation (2002) 0.76